-0.000145560407569216 -0.00145560407569133 -0.000145560407569216 -0.000145560407569216 0 0.00262008733624464 0.00131004366812232 0.00087336244541488
Sign Up Today X
Thanks for submitting the form.
Stockreport

Gilead Sciences stock jumps on HIV treatment trial success [Yahoo! Finance Canada]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Yahoo! Finance Canada
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
results for its HIV treatment trial, claiming it's the first Phase 3 HIV prevention trial ever to show zero Infections. Market Domination Anchors Josh Lipton and Julie Hyman break down the latest development for Gilead Sciences and what it could mean for the company moving forward For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Nicholas Jacobino Video Transcript Now let's get to some trending tickers. First of Gilead Sciences. The shares of 8% after announcing that it's experimental twice yearly medicine to prevent HIV demonstrate demonstrated 100% efficacy for the investigation. Use in cisgender women in Africa, women and adolescent girls. So the company has some, um, medications on the market already. Um, but they either are daily oral. Or perhaps you have to do them as shots every months, so this is less frequent. So the hope is, is that this will be there will be more [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

Gilead Sciences stock jumps on HIV treatment trial success [Yahoo! Finance Canada]

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: Yahoo! Finance Canada
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
results for its HIV treatment trial, claiming it's the first Phase 3 HIV prevention trial ever to show zero Infections. Market Domination Anchors Josh Lipton and Julie Hyman break down the latest development for Gilead Sciences and what it could mean for the company moving forward For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Nicholas Jacobino Video Transcript Now let's get to some trending tickers. First of Gilead Sciences. The shares of 8% after announcing that it's experimental twice yearly medicine to prevent HIV demonstrate demonstrated 100% efficacy for the investigation. Use in cisgender women in Africa, women and adolescent girls. So the company has some, um, medications on the market already. Um, but they either are daily oral. Or perhaps you have to do them as shots every months, so this is less frequent. So the hope is, is that this will be there will be more [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS